| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 02/15/2000 | US6025165 Producing single-chain molecules of the binding portions of variable regions of light and heavy chains joined by peptide linker, dissociating then reassociating the molecules, separating out and recovering multivalent proteins |
| 02/15/2000 | US6025144 Immunoassay test kit for measuring bone resorption |
| 02/15/2000 | US6025129 Remotely programmable matrices with memories and uses thereof |
| 02/15/2000 | US6024953 Prevention of rabies in mammals, administering a hybrid vaccine |
| 02/15/2000 | CA2168552C Refolding of polypeptides like recombinant insulin-like growth factor igf-1 |
| 02/10/2000 | WO2000006742A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 02/10/2000 | WO2000006741A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 02/10/2000 | WO2000006740A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 02/10/2000 | WO2000006739A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 02/10/2000 | WO2000006587A1 New cofactors for methyltransferases |
| 02/10/2000 | WO1999063944A3 Novel therapeutic agents that modulate estrogen receptors |
| 02/10/2000 | WO1999054728A3 Method of predicting receptor modulating activity |
| 02/10/2000 | DE19852216C1 Removal of albumin from cell culture supernatant by dialysis in the presence of cathepsin D |
| 02/10/2000 | DE19822823A1 Neue Peptidfragmente zur Reinigung von Proteinen New peptide fragments in protein purification |
| 02/10/2000 | CA2337493A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 02/10/2000 | CA2337092A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 02/10/2000 | CA2336708A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 02/10/2000 | CA2336532A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 02/09/2000 | EP0977726A1 Process for esterification of amino acids and peptides |
| 02/09/2000 | EP0822934B1 Antithrombotic amidinotetrahydropyridylalanine derivatives |
| 02/09/2000 | EP0632815B1 Sequential degradation of proteins and peptides from the n-terminus |
| 02/09/2000 | CN1244218A Characterising polypeptides |
| 02/09/2000 | CN1049220C Preparation of pentaccordinate phosphinylidyne-amino-acid mixed anhydride and its method for synthetizing polypeptide |
| 02/08/2000 | US6022966 Conjugate comprises a dota chelate component, a biotin component and a linker component resistant to biotinidase cleavage |
| 02/08/2000 | US6022954 Process for the preparation of purified albumin solutions |
| 02/08/2000 | US6022848 Inhibitor of stem cell proliferation and uses thereof |
| 02/08/2000 | US6022722 Regeneration of denatured polypeptide; contacting a denatured polypeptide adsorbed to solid support with trifluoroethanol |
| 02/08/2000 | US6022524 Conjugating amino groups of macromolecules with activated polycarboxylic chelants; removing unreacted chelant, forming metal complex of conjugate, reacting complex with chelant and again complexing with metal; high content of chelants groups |
| 02/08/2000 | US6022477 Passing feed solution into membrane module to separate bioproducts from feed solution by permeation; allowing permeated bioproducts to contact adsorbent particles; fractionating and purifying retained products |
| 02/08/2000 | CA2003794C Expression of hiv proteins in drosophila cells |
| 02/03/2000 | WO2000005357A1 Labeled complex, process for producing the same and process for utilizing the same |
| 02/03/2000 | WO2000005261A1 Clarification of protein precipitate suspensions using anionic polymeric flocculants |
| 02/03/2000 | WO2000005251A1 Aerothricin analogs, their preparation and use |
| 02/03/2000 | WO2000005247A1 Method for crystallizing maleic acid salt of n-(1(s)-ethoxycarbonyl-3-phenylpropyl)-l-alanyl-l-proline |
| 02/03/2000 | WO2000005243A2 Resin derivatization method and uses thereof |
| 02/03/2000 | WO2000005208A1 Amino-aldehyde solid support, linker therefor and methods of preparation and use thereof |
| 02/03/2000 | WO1999063936A3 Novel therapeutic agents that modulate endothelin receptors |
| 02/03/2000 | WO1999063933A3 Multivalent agonists, partial agonists and antagonists of the gaba receptors |
| 02/03/2000 | WO1999061475A8 Method for separating and/or isolating plasma proteins by annularchromatography |
| 02/03/2000 | WO1999058947A3 Modulation of molecular interaction sites on rna and other biomolecules |
| 02/03/2000 | WO1999058474A9 Generation of combinatorial libraries of compounds corresponding to virtual libraries of compounds |
| 02/03/2000 | DE19831758A1 Ligandenbestimmung für Proteine Ligands for proteins determination |
| 02/03/2000 | CA2338345A1 Encapsulation of water soluble peptides |
| 02/03/2000 | CA2338319A1 Clarification of protein precipitate suspensions using anionic polymeric flocculants |
| 02/03/2000 | CA2302832A1 Method for crystallizing maleic acid salt of n-(1(s)-ethoxycarbonyl-3-phenylpropyl)-l-alanyl-l-proline |
| 02/02/2000 | EP0976765A1 Process for the preparation of a protein solution |
| 02/02/2000 | EP0976759A2 Preparation of protein formulations with reduced content of aggregates |
| 02/02/2000 | EP0976758A1 Use of porous membranes, either neutrally or negatively charged, as a loading material for gel electrophoresis |
| 02/02/2000 | EP0976701A1 Design method of physiologically active compound |
| 02/02/2000 | EP0975964A1 In situ identification of target structures e.g. in vivo selection method for a phage library |
| 02/02/2000 | EP0975671A1 Method of chromatographically purifying or fractionating von willebrand factor from a vwf-containing starter material |
| 02/02/2000 | EP0975665A1 Active substance and composition inhibiting tumorous proliferation in ectoderm derived tissues |
| 02/02/2000 | EP0975658A2 Purification of peptides and oligonucleotides by sample displacement chromatography process and apparatus |
| 02/02/2000 | EP0975657A1 Method of purifying protein from inclusion bodies |
| 02/02/2000 | EP0975355A2 Hexameric fusion proteins and uses therefor |
| 02/02/2000 | EP0584136B1 Determination of motifs of peptides on mhc molecules |
| 02/02/2000 | EP0539530B1 Purification directed cloning of peptides |
| 02/02/2000 | EP0397834B1 Method for identifying active domains and amino acid residues in polypeptides and hormone variants |
| 02/01/2000 | US6020537 Prion protein standard and method of making same |
| 02/01/2000 | US6020469 Freeze drying (lyophilization) is considered useful and effective for preservation of many biologically active materials. |
| 02/01/2000 | US6020460 Conformationally stabilized cell adhesion peptides |
| 02/01/2000 | US6020312 Synthetic antibiotics |
| 02/01/2000 | US6020188 Polynucleotides encoding platelet endothelial cell adhesion molecule (PECAM-1) and fragments thereof |
| 02/01/2000 | US6020182 Subunit respiratory syncytial virus vaccine preparation |
| 02/01/2000 | US6020177 Heptaprenyl diphosphate-synthetase |
| 02/01/2000 | US6020176 Converting copalyl pyrophosphate to ent-kaurene and are useful for the regulation of plant growth. |
| 02/01/2000 | US6020141 Microplate thermal shift assay for ligand development and multi-variable protein chemistry optimization |
| 02/01/2000 | CA2047681C Vaccines for nontypable haemophilus influenzae |
| 02/01/2000 | CA1340888C Vaccines and diagnostic assays for haemophilus influenzae |
| 02/01/2000 | CA1340887C Sialic acid glycosides, antigens, immunoadsorbents, and methods for thier preparation |
| 01/27/2000 | WO2000004384A1 Device and method for the determination of protein domain boundaries |
| 01/27/2000 | WO2000004380A1 Determination of ligands for proteins |
| 01/27/2000 | WO2000004044A1 Glycopeptide antibiotics, combinatorial libraries of glycopeptide antibiotics and methods of producing same |
| 01/27/2000 | WO1999063930A3 Novel angiotensin receptor modulators and their uses |
| 01/27/2000 | CA2337353A1 Device and method for the determination of protein domain boundaries |
| 01/27/2000 | CA2337103A1 Glycopeptide antibiotics, combinatorial libraries of glycopeptide antibiotics and methods of producing same |
| 01/26/2000 | EP0974655A2 G-CSF analog compositions and methods |
| 01/26/2000 | EP0974111A1 Apparatus and method for automated protein design |
| 01/26/2000 | EP0974054A1 Combinatorial chemistry system and method of use |
| 01/26/2000 | EP0973936A1 Combinatorial libraries of peptidomimetic aminothioether acids |
| 01/26/2000 | EP0973909A2 Process for extracting and purifying recombinant, non-lipidised osp-protein |
| 01/26/2000 | EP0973885A1 Disassociation of interacting molecules |
| 01/26/2000 | EP0973878A1 Controlled dissolution cross-linked protein crystals |
| 01/26/2000 | EP0973806A1 Site protected protein modification |
| 01/26/2000 | EP0973794A1 Netrin receptors |
| 01/26/2000 | EP0973530A1 Serum-derived factor inducing cell differentiation and medical uses thereof |
| 01/26/2000 | CN1242375A Method for directly and simply extracting FI protein from plant leaves |
| 01/25/2000 | US6018026 For rapid, inexpensive and adaptable high volume screening of ligands to receptors; for determining the presence of cell growth factors in samples; for purifying cell growth factors and isoforms |
| 01/25/2000 | US6017879 Template associated NPY Y2-receptor agonists |
| 01/25/2000 | US6017876 Monosuccinylated exclusively a n-terminus |
| 01/25/2000 | US6017731 Nucleotide sequences encoding a signal sequence, a propeptide leader sequence, a preferred processing site cleaved in situ by a yeast proteolytic enzyme; expressing mammalian proteins and their secretion in a biologically active mature form |
| 01/25/2000 | US6017719 Targeting cells from heterogeneous suspension; forming cell complexes linked to antibody bound to surface antigen, separating complexes, mixing antibody with peptide that binds and displaces antibody from antigen, releasing target cell |
| 01/25/2000 | US6017696 Controlling nucleic acid hybridization by connecting multiple electrical sources to several location where a plurality of nucleic acids with target nucleic acids are attached, apply a negative potential, removing non specific nucleic acid |
| 01/25/2000 | US6017693 Analyzing oligonucleotide fragments, comparing to calculated mass spectra of nucleotide sub-sequences stored in database, calculating closeness-of-fit measure to determine best matches |
| 01/25/2000 | US6017539 Multimeric hybrid genes encoding corresponding chimeric protein comprise gene sequence coding for antigenic region of protein from first pathogen linked to gene sequence coding for antigenic region of protein from second pathogen |
| 01/25/2000 | US6017510 Radioisotope of technetium-99m labeled leukocyte-binding peptides; scintographic imaging of sites of infection and inflammation; peptide derived from platelet factor 4, a bacterially-derived chemotactic peptide, fibrinopeptide |
| 01/25/2000 | US6017496 Matrices with memories and uses thereof |
| 01/25/2000 | CA2190268C Sterile and pyrogen-free columns coupled to protein for binding and removal of substances from blood |
| 01/20/2000 | WO2000003011A2 METHOD FOR PRODUCING A PEPTIDE WITH A pI ABOVE 8 OR BELOW 5 |
| 01/20/2000 | WO2000002921A1 Method for purifying hemoglobin |